Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000187672 | SCV000241269 | pathogenic | not provided | 2013-10-11 | criteria provided, single submitter | clinical testing | p.F210LfsX10: c.627delC in the GRIN2A gene (NM_000833.3). The c.627delC mutation in the GRIN2A gene has not been reported previously, to our knowledge. This mutation causes a frameshift starting with codon Phenylalanine 210, changes this amino acid to a Leucine residue and creates a premature Stop codon at position 10 of the new reading frame, denoted p.Phe210LeufsX10 (F210LfsX10). This mutation is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Although this mutation has not been previously reported to our knowledge, loss of function due to a nonsense mutation in GRIN2A has been reported previously in association with a GRIN2A-related phenotype (Endele et al., 2010). We interpret c.627delC as a disease-causing mutation. This variant has been observed de novo without verified parentage. The variant is found in GRIN2A panel(s). |
Institute of Human Genetics, |
RCV001781552 | SCV002026169 | likely pathogenic | Landau-Kleffner syndrome | 2019-01-01 | criteria provided, single submitter | research |